1. Deoxycholic acid: risk of injection-site necrosis

   News item 04 September 2021 Pages: 1 - 1

2. MRHA recalls batch of metformin oral solution due to nitrosamine

   News item 04 September 2021 Pages: 2 - 2

3. Recall of pms-PROGESTERONE in Canada

   News item 04 September 2021 Pages: 3 - 3

4. Risks and benefits of dihydrocodeine reviewed in NZ

   Unknown 04 September 2021 Pages: 4 - 4

5. Voluntary recall of further varencicline lots due to impurity

   News item 04 September 2021 Pages: 5 - 5

6. Adverse events in elderly hospitalised patients mostly preventable

   Clinical study 04 September 2021 Pages: 6 - 6

7. Antihypertensives: sex differences in risk of COVID-19

   Clinical study 04 September 2021 Pages: 7 - 7

8. AstraZeneca COVID-19 vaccine-related thrombocytopenia and thrombosis

   Clinical study 04 September 2021 Pages: 8 - 8

9. Concomitant psychotropics increase risk of opioid-related death

   Clinical study 04 September 2021 Pages: 9 - 9

10. Increased risk of aripiprazole-related AEs in children with autism

    Clinical study 04 September 2021 Pages: 10 - 10

11. Serious safety events in children's hospitals in USA

    Clinical study 04 September 2021 Pages: 11 - 11

12. Thrombocytopenia and thromboembolism after COVID-19 vaccination

    Clinical study 04 September 2021 Pages: 12 - 12

13. Other adverse reaction research

    News item 04 September 2021 Pages: 13 - 13

14. Silybum marianum

    Case report 04 September 2021 Pages: 14 - 14

15. Abemaciclib/glimepiride

    Case report 04 September 2021 Pages: 15 - 15

16. ACE inhibitors/complement C1-inhibitor protein

    Case report 04 September 2021 Pages: 16 - 16

17. Acenocoumarol

    Case report 04 September 2021 Pages: 17 - 17

18. Acetazolamide

    Case report 04 September 2021 Pages: 18 - 18

19. Acetazolamide

    Case report 04 September 2021 Pages: 19 - 19

20. Aciclovir/antineoplastics /mycophenolate-mofetil

    Case report 04 September 2021 Pages: 20 - 20

21. Adalimumab

    Case report 04 September 2021 Pages: 21 - 21

22. Adalimumab/azathioprine

    Case report 04 September 2021 Pages: 22 - 22

23. Adalimumab/celecoxib/infliximab

    Case report 04 September 2021 Pages: 23 - 23

24. Afatinib/cetuximab/erlotinib

    Case report 04 September 2021 Pages: 24 - 24

25. Albendazole/phenytoin

    Case report 04 September 2021 Pages: 25 - 25

26. Albumin human/antineoplastics/terlipressin

    Case report 04 September 2021 Pages: 26 - 26

27. Alcohol/metformin interaction

    Case report 04 September 2021 Pages: 27 - 27

28. Alprostadil/papaverine/phentolamine

    Case report 04 September 2021 Pages: 28 - 28

29. Amiodarone

    Case report 04 September 2021 Pages: 29 - 29

30. Amiodarone/propafenone/verapamil

    Case report 04 September 2021 Pages: 30 - 30

31. Amoxicillin/ciclosporin

    Case report 04 September 2021 Pages: 31 - 31

32. Amoxicillin/clarithromycin

    Case report 04 September 2021 Pages: 32 - 32

33. Amoxicillin/clavulanic-acid and clarithromycin

    Case report 04 September 2021 Pages: 33 - 33

34. Amphotericin B liposomal/caspofungin/micafungin

    Case report 04 September 2021 Pages: 34 - 34

35. Amphotericin-B liposomal/voriconazole

    Case report 04 September 2021 Pages: 35 - 35

36. Amphotericin-B-liposomal

    Case report 04 September 2021 Pages: 36 - 36

37. Amphotericin-B-liposomal/micafungin/voriconazole

    Case report 04 September 2021 Pages: 37 - 37

38. Antibacterials

    Case report 04 September 2021 Pages: 38 - 38

39. Antibacterials

    Case report 04 September 2021 Pages: 39 - 39

40. Antibacterials

    Case report 04 September 2021 Pages: 40 - 40

41. Antibacterials/caspofungin

    Case report 04 September 2021 Pages: 41 - 41

42. Antibacterials/dipyrone

    Case report 04 September 2021 Pages: 42 - 42

43. Antidepressants

    Case report 04 September 2021 Pages: 43 - 43

44. Antiepileptic-drugs

    Case report 04 September 2021 Pages: 44 - 44

45. Antifungals

    Case report 04 September 2021 Pages: 45 - 45

46. Antihistamines/betamethasone/immunostimulants

    Case report 04 September 2021 Pages: 46 - 46

47. Antihypertensives

    Case report 04 September 2021 Pages: 47 - 47

48. Antineoplastics

    Case report 04 September 2021 Pages: 48 - 48

49. Antineoplastics

    Case report 04 September 2021 Pages: 49 - 49

50. Antineoplastics

    Case report 04 September 2021 Pages: 50 - 50